Citigroup
IBBQ icon

Citigroup’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Citigroup’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$2.37M – 6454
2021
Q4 		$2.37M Sell
100,000
-300,000
-75% -$7.31M ﹤0.01% 2476
2021
Q3 		$10.2M Hold
400,000
– – 0.01% 1397
2021
Q2 		$10.4M Buy
+400,000
New +$10.2M 0.01% 1393

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
AF
Apexium Financial Dallas, Texas $2.06B AUM 15.96% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return

Citigroup's IBBQ Position: Q1 2022 in Review

Citigroup sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2022, closing a stake of 100,000 shares — an estimated $2.37M sold.

Citigroup first reported a position in IBBQ in Q2 2021 and held it in 3 quarters. The position peaked at $10.4M in Q2 2021. 11 funds tracked by Wall St. Rank hold IBBQ as of Q1 2022.

  • Citigroup reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • Citigroup sold 100,000 Invesco NASDAQ Biotechnology ETF shares in Q1 2022, an estimated $2.37M.
  • Citigroup first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and held it in 3 quarters.
  • Citigroup's Invesco NASDAQ Biotechnology ETF position peaked at $10.4M in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2022.

Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.